Abstract:
BACKGROUND:Fast relief of migraine pain, associated symptoms, and migraine-related disability are priorities in the acute treatment of migraine. Efforts to improve the pharmacokinetic profiles of acute migraine treatments with the aim of providing faster relief include the development of non-oral routes of administration. AVP-825 (ONZETRA® Xsail® ) is a delivery system containing 22 mg sumatriptan powder that uses a patient's own breath to deliver medication intranasally, targeting the upper posterior nasal cavity beyond the narrow nasal valve, an area lined with vascular mucosa conducive to rapid drug absorption into the systemic circulation. While most studies comparing treatments measure differences in proportions of patients achieving a dichotomous endpoint at fixed time intervals, in this study we compare trajectories of migraine pain and disability over time for AVP-825 versus 100 mg oral sumatriptan tablets. METHODS:We used data from the COMPASS study (NCT01667679, clinicaltrials.gov), a double-blind, double-dummy, active-comparator, cross-over study of people with a diagnosis of migraine. Participants treated up to five qualifying migraine attacks within 1 hour of onset with either AVP-825 plus placebo tablets or 100 mg oral sumatriptan tablets plus placebo delivery system during the first of two 12-week treatment periods, and then switched treatment sequences to treat up to five more attacks in the second treatment period. Patients recorded ordinal migraine pain intensity and migraine-related disability before dosing (predose), and at 10, 15, 30, 45, 60, 90 and 120 minutes. Three-level ordinal multilevel models accounted for unique data structure (repeated measures nested within attacks for each patient) and tested for treatment differences in migraine pain and migraine-related disability through the first 2 hours of attacks post dose. RESULTS:Among 259 study participants (mean age 40.0 years, 84.6% female, 78.4% white), there was significant between and within person variability in migraine pain intensity and migraine-related disability. A typical individual showed significantly faster reductions in migraine pain over the first 30 minutes and migraine-related disability over the first 45 minutes when treating with AVP-825 compared with oral sumatriptan. Overall levels of pain and disability also favored AVP-825 over 2 h following treatment. Model-based odds ratios (OR) comparing AVP-825 to oral sumatriptan ranged from 0.38 to 0.76 for pain and 0.37 to 0.65 for disability, with OR <1 indicating reduced pain/disability in the AVP-825 condition. CONCLUSIONS:Compared with 100 mg oral sumatriptan, treatment with AVP-825 was associated with faster reductions in migraine pain intensity and migraine-related disability starting at 10 minutes postdose and continuing through the first 30 minutes for migraine pain intensity and the first 45 minutes for migraine-related disability, resulting in lower overall pain intensity and disability that lasted through the first 2 h following treatment. Both migraine pain intensity and disability varied substantially both across subjects and within subjects across attacks.
journal_name
Headachejournal_title
Headacheauthors
Lipton RB,McGinley JS,Shulman KJ,Wirth RJ,Buse DCdoi
10.1111/head.13165subject
Has Abstractpub_date
2017-11-01 00:00:00pages
1570-1582issue
10eissn
0017-8748issn
1526-4610journal_volume
57pub_type
杂志文章,随机对照试验相关文献
HEADACHE文献大全abstract:OBJECTIVE:To explore the effects of olmesartan on frequency and severity of migraine attacks in patients with comorbid hypertension and prehypertension. BACKGROUND:A randomized, double-blind, placebo-controlled, crossover study with a total of 60 patients has demonstrated the efficacy and safety of the angiotensin II ...
journal_title:Headache
pub_type: 杂志文章,随机对照试验
doi:10.1111/j.1526-4610.2006.00382.x
更新日期:2006-03-01 00:00:00
abstract::Nasal signs and symptoms commonly accompany cephalgia in some headache syndromes. Head pain associated with sinusitis is also fairly well-recognized. However, referred cephalgia of rhinogenic origin, in the absence of sinonasal symptoms or disease, is poorly understood. We report a case of a patient with chronic and s...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.1994.hed3404226.x
更新日期:1994-04-01 00:00:00
abstract:OBJECTIVE:To review and analyze published reports on the acute treatment of migraine headache with triptans, dihydroergotamine (DHE), and magnesium in emergency department, urgent care, and headache clinic settings. METHODS:MEDLINE was searched using the terms "migraine" and "emergency," and "therapy" or "treatment." ...
journal_title:Headache
pub_type: 杂志文章,评审
doi:10.1111/j.1526-4610.2011.02062.x
更新日期:2012-01-01 00:00:00
abstract:OBJECTIVE:The aim of this study was to evaluate the prevalence, demographic, clinical features, and possible risk factors for hemodialysis headache (HDH). BACKGROUND:HDH has been recognized for many years, but the pathophysiology of this condition is not known. High arterial blood pressure, decreased serum osmolality,...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2006.00295.x
更新日期:2006-01-01 00:00:00
abstract:OBJECTIVE:To evaluate the prevalence of migraine/severe headaches in those with and without general obesity and abdominal obesity (Abd-O) and the effect of gender and age on this relationship. BACKGROUND:General, or total body obesity (TBO), as estimated by body mass index, is a risk factor for migraine chronification...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2009.01459.x
更新日期:2010-01-01 00:00:00
abstract::Neurotologic symptoms are common with migraine, yet relatively little is known about the pathophysiology of such symptoms. Motion sensitivity with bouts of motion sickness occurs in about two thirds of patients with migraine. Episodes of vertigo occur in about one fourth of patients and, in some, vertigo is the only s...
journal_title:Headache
pub_type: 杂志文章,评审
doi:10.1046/j.1526-4610.1997.3710615.x
更新日期:1997-11-01 00:00:00
abstract::Several second-generation triptans have been introduced that differ in their pharmacologic profiles relative to each other and to sumatriptan. As therapeutic options multiply, clinicians must be able to distinguish among these compounds. Recently, a meta-analysis was conducted on data from 53 double-blind, randomized,...
journal_title:Headache
pub_type: 杂志文章
doi:10.1046/j.1526-4610.2002.0420s1018.x
更新日期:2002-01-01 00:00:00
abstract:OBJECTIVE:To investigate the associations between interictal pattern glare, visual stress, and visual triggers of migraine. BACKGROUND:There has been relatively little research on the visual stimuli that can trigger migraine episodes. This is surprising, since if practitioners can obviate such triggers, then some atta...
journal_title:Headache
pub_type: 杂志文章,多中心研究
doi:10.1111/j.1526-4610.2006.00585.x
更新日期:2006-10-01 00:00:00
abstract:BACKGROUND:Recent studies have found a strong relationship between tobacco smoking and headache pain. It remains unclear whether smoking behavior leads to headache or visa versa, mainly due to the cross-sectional nature of the majority of this research. OBJECTIVE:To help clarify the direction of the relation between s...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2007.01037.x
更新日期:2008-04-01 00:00:00
abstract::We report the case of a man who suffered from Valsalva-induced cluster headaches. The headaches deviated from classic cluster in that they were solely induced by activity involving the Valsalva maneuver, such as coughing and sneezing, and never occurred spontaneously. The attacks were prevented by treatment with indom...
journal_title:Headache
pub_type: 杂志文章
doi:10.1046/j.1526-4610.2002.02088.x
更新日期:2002-04-01 00:00:00
abstract:BACKGROUND:Though thyroid growths are considered to be a frequent cause of Horner's syndrome, concurrent headache attacks are not commonly seen. CASE:A 63-year-old woman presented with severe, daily occurring, unilateral headache attacks with ipsilateral Horner's syndrome. Magnetic resonance imaging arteriography show...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/head.12315
更新日期:2014-09-01 00:00:00
abstract:OBJECTIVE:To determine the potential impact of erenumab, a human anti-calcitonin gene-related peptide (CGRP) receptor monoclonal antibody, on total exercise time (TET), time to exercise-induced angina, and ST depression in a double-blind, placebo-controlled study in patients with stable angina due to documented coronar...
journal_title:Headache
pub_type: 杂志文章,多中心研究,随机对照试验
doi:10.1111/head.13316
更新日期:2018-05-01 00:00:00
abstract::The presence of postural, myofascial, and mechanical abnormalities in patients with migraine, tension-type headache, or both headache diagnoses was compared to a headache-free control sample. Twenty-four control subjects were obtained from a convenience sampling and each was matched by age and sex to three patients wi...
journal_title:Headache
pub_type: 杂志文章
doi:10.1046/j.1526-4610.1999.3901021.x
更新日期:1999-01-01 00:00:00
abstract:OBJECTIVE:To determine the predictability of future migraine attacks and to describe the effect of migraine on daily life during and between migraine attacks. BACKGROUND:Migraine is associated with substantial economic and humanistic burden. There is growing evidence that early intervention with triptans results in be...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2010.01630.x
更新日期:2010-09-01 00:00:00
abstract:BACKGROUND AND OBJECTIVES:Migraine headache is the seventh leading cause of disability worldwide causing adverse outcomes in many aspects of an individual's life. Many psychological aspects affect chronic migraine (CM): illness perception, anxiety, depressive symptoms, and job satisfaction. This observational study aim...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/head.13461
更新日期:2019-01-01 00:00:00
abstract:BACKGROUND:Migraine is a common and often debilitating neurological disease. It can be divided into episodic and chronic subforms based on the number of monthly headache days. Because only a subset of individuals with episodic migraine (EM) progress to chronic migraine (CM) over any given time period, understanding the...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/head.13459
更新日期:2019-03-01 00:00:00
abstract::A retrospective study was conducted on 1300 women suffering from migraine without aura referred to the Headache Centers of Parma and Pavia from 1984 to 1990. All the data concerning their reproductive life, and the modifications induced by it on the course of headache were obtained from record-charts. Migraine frequen...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.1993.hed3307385.x
更新日期:1993-07-01 00:00:00
abstract:OBJECTIVE:To examine the likelihood of response with continued galcanezumab treatment in patients with episodic or chronic migraine without initial clinical improvement. BACKGROUND:A percentage of patients with migraine may require additional time on pharmacotherapy but discontinue treatment prematurely. Additionally,...
journal_title:Headache
pub_type: 杂志文章,随机对照试验
doi:10.1111/head.13443
更新日期:2019-02-01 00:00:00
abstract:BACKGROUND:We previously showed that migraine and tension-type headache (TTH) have a high prevalence that differs markedly between social groups. Here, we aim to identify factors associated with migraine and TTH (possible risk factors) in three social groups to better understand the difference in prevalence between sex...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/head.12757
更新日期:2016-02-01 00:00:00
abstract:BACKGROUND:Migraine is frequently comorbid with major depressive disorder, the presence of which confers increased disability and various clinical challenges. METHODS/RESULTS:The present article reviews empirically supported pharmacologic and cognitive-behavioral interventions for depression, as well as the emerging y...
journal_title:Headache
pub_type: 杂志文章,评审
doi:10.1111/head.12521
更新日期:2015-02-01 00:00:00
abstract:OBJECTIVE:To assess urinary 6-sulphatoxymelatonin levels in a large consecutive series of patients with migraine and several comorbidities (chronic fatigue, fibromyalgia, insomnia, anxiety, and depression) as compared with controls. BACKGROUND:Urine analysis is widely used as a measure of melatonin secretion, as it is...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2009.01547.x
更新日期:2010-03-01 00:00:00
abstract::Orthostatic headache is a key symptom of intracranial hypotension; however, not all orthostatic headaches are caused by cerebrospinal fluid leaks leading to intracranial hypotension. We report here the unusual case of a 68-year-old man presenting with orthostatic headache in which compression of the C3 spinal nerve ro...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2007.00982.x
更新日期:2008-01-01 00:00:00
abstract:OBJECTIVES/BACKGROUND:We herein investigated the role of polymorphisms in calcitonin gene-related peptide (CGRP)-related genes looking at the association of rs3781719 (T > C) in the calcitonin gene-related polypeptide-alpha (CALCA) gene and of rs3754701 (T > A) and rs7590387 (C > G) at the receptor activity modifying 1...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/head.12559
更新日期:2015-05-01 00:00:00
abstract::Migraine is a debilitating condition characterized by a cycle of painful headaches and headache-related symptoms interspersed with periods of worry, distress, and apprehension. The negative impact of migraine on patient functioning, workplace productivity, and other daily activities has been demonstrated through the u...
journal_title:Headache
pub_type: 杂志文章,评审
doi:10.1111/j.1526-4610.2007.01040.x
更新日期:2008-04-01 00:00:00
abstract::Genetic mutations of sporadic hemiplegic migraine (SHM) are mostly unknown. SHM pathophysiology relies on cortical spreading depression (CSD), which might be responsible for ischemic brain infarction. Cystic fibrosis (CF) is caused by a monogenic mutation of the chlorine transmembrane conductance regulator (CFTR), pos...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/head.13472
更新日期:2019-02-01 00:00:00
abstract:BACKGROUND:Borderline personality disorder (BPD) may be disproportionately common in the migraine patient population, but specific migraine features in the BPD subgroup remain incompletely characterized. PURPOSE:To define more clearly the clinical characteristics of migraine patients with BPD, to evaluate their clinic...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2007.00649.x
更新日期:2007-01-01 00:00:00
abstract:OBJECTIVE:To assess the psychometric properties of a new patient-reported migraine instrument, the Completeness of Response Survey (CORS), which measures a comprehensive set of factors important to patients' decisions regarding the initiation and continuation of treatment. BACKGROUND:Traditionally, migraine treatments...
journal_title:Headache
pub_type: 杂志文章,多中心研究
doi:10.1111/j.1526-4610.2012.02099.x
更新日期:2012-04-01 00:00:00
abstract::Although severe short-lasting headaches are rare, they can be considered disabling conditions with a major impact on the quality of life of patients. These headaches can divided broadly in to those associated with autonomic symptoms, so called trigeminal autonomic cephalgias (TACs), and those with few or no autonomic ...
journal_title:Headache
pub_type: 杂志文章,评审
doi:10.1111/head.12213
更新日期:2013-10-01 00:00:00
abstract::If you vomit with migraines, get full-blown migraines upon awakening, or want rapid relief without injections, consider a nasal spray. Options include triptans (zolmitriptan [Zomig] or sumatriptan [Imitrex]), DHE (Migranal), or an NSAID (Sprix). ...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/head.12045
更新日期:2013-03-01 00:00:00
abstract::Biomarkers are physical signs or laboratory measurements that occur in association with a pathological process and have putative diagnostic and/or prognostic utility. In migraine, clinical, radiological, and biochemical biomarkers might be helpful to improve diagnosis, get insight in pathophysiology, and facilitate tr...
journal_title:Headache
pub_type: 杂志文章,评审
doi:10.1111/j.1526-4610.2006.00499.x
更新日期:2006-07-01 00:00:00